Mushroom extract supplements and cancer: the evidence

This page is for people with cancer who are curious about mushroom supplements. It covers what the research shows, what it does not, and how to talk with your team about it.

Mushroom supplements often get lumped in with the internet's worst health advice. That is not quite fair. NCI keeps a full summary on medicinal mushrooms, and it describes real clinical research.

More than 100 species are used medicinally in Asian countries, NCI says, with reishi, turkey tail, shiitake and maitake among the most familiar. The parts under study include:

• Polysaccharides (complex sugars) such as beta-glucans
• Triterpenoids, lipids (fats) and proteins

NCI says their immune effects involve stimulating immune cells.

So this is not folklore alone. But what the research actually shows is narrower than the marketing suggests.

The strongest evidence concerns turkey tail extract, known as polysaccharide-K, or PSK.

NCI cites a review of eight randomized controlled trials covering 8,009 patients with gastric cancer. The PSK was added to chemotherapy. It reported an overall survival hazard ratio of 0.88, with a 95% confidence interval of 0.79 to 0.98. (A number below one means the PSK group did somewhat better.) For colorectal cancer, it cites an analysis of three trials (1,094 patients). It reports a five-year overall survival odds ratio of 0.71, with a confidence interval of 0.55 to 0.90, favoring PSK.

For reishi, NCI describes a Japanese study of 123 people with colorectal adenomas (growths that can turn into cancer). Adenoma measures went down in the reishi group and up in the control group. Other reishi work NCI describes was in lab models.

Read those trials closely and one thing stands out. PSK was given alongside standard cancer treatment, not instead of it. These were people already getting standard care, with an extract added on top.

That distinction gets lost the moment a supplement is sold online. Nobody in those studies swapped mushroom capsules in for surgery or chemotherapy. So the results say nothing about doing that.

No part of this evidence supports choosing a mushroom extract over the treatment your team has recommended.

NCI is direct: the FDA has not approved medicinal mushrooms as a treatment for cancer, or for any other medical condition.

Approval status matters. Unlike drugs, supplements do not need FDA review and approval before they are sold.

NCI is clear on this point. Unlike drugs, dietary supplements do not need FDA review and approval before they go on sale. Ingredients can vary a lot from batch to batch. There is no guarantee the ingredients listed on the label are actually there, or in the amounts stated.

If you buy a mushroom extract, you cannot be sure this month's bottle matches last month's. You also cannot be sure either one matches the extract used in a trial.

Many people want to do something active while getting treatment. That instinct is healthy, and mushroom supplements are one of the gentler ways it shows up.

If you are thinking about one:

• Tell your oncology team, and let them add it to your medication list.
• Ask specifically about interactions with your treatment, and about your blood counts and liver tests.
• Do not delay or replace any part of your recommended treatment.
• Be skeptical of any seller promising a cure, shrinkage, or a survival figure. The published evidence does not support those claims.

It is disappointing to reach the end of a page like this and find no clear yes. But false hope has a cost that shows up later, often at the worst time. Honest uncertainty, given early, is easier to plan around.